13 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 26176234 | Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients. | 2015 | 1 |
2 | 24641623 | Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability. | 2014 Jun | 1 |
3 | 23670235 | Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751. | 2013 Jul | 1 |
4 | 23917319 | Human biotransformation of the nonnucleoside reverse transcriptase inhibitor rilpivirine and a cross-species metabolism comparison. | 2013 Oct | 1 |
5 | 22050083 | Quantification of human uridine-diphosphate glucuronosyl transferase 1A isoforms in liver, intestine, and kidney using nanobore liquid chromatography-tandem mass spectrometry. | 2012 Jan 3 | 1 |
6 | 21632963 | Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities. | 2011 Sep | 1 |
7 | 21780761 | Characterization of dibenzo[a,l]pyrene-trans-11,12-diol (dibenzo[def,p]chrysene) glucuronidation by UDP-glucuronosyltransferases. | 2011 Sep 19 | 1 |
8 | 20713656 | Metabolism of 1'- and 4-hydroxymidazolam by glucuronide conjugation is largely mediated by UDP-glucuronosyltransferases 1A4, 2B4, and 2B7. | 2010 Nov | 2 |
9 | 16884532 | Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants. | 2006 | 1 |
10 | 14744950 | Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of posaconazole (Noxafil). | 2004 Feb | 4 |
11 | 11408353 | N-glucuronidation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N_hydroxy-PhIP by specific human UDP-glucuronosyltransferases. | 2001 Jul | 2 |
12 | 11560879 | Tertiary N-glucuronides of clozapine and its metabolite desmethylclozapine in patient urine. | 2001 Oct | 2 |
13 | 10051052 | Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation. | 1999 Feb | 1 |